top of page

SF Healthcare Week: Baird's Brian Skorney gives his take on Monday morning's conference news

Brian Skorney comments on the Ambrx and Harpoon acquisitions, the year ahead in biotech, and his top picks Biogen, Neurocrine, and Biohaven.





Comentarios


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page